DelMar Pharmaceuticals Inc (OTCQB:DMPI)

Data as of Oct 22
 +0.0099 / +1.24%
Today’s Change
Today|||52-Week Range
Distribution Services
Wholesale Distributors

Company Description

DelMar Pharmaceuticals, Inc. is a development stage company with a focus on the development of drugs for the treatment of cancer. Its products include VAL-083, Drug Discovery and Patents & Intellectual Property. DelMar Pharmaceuticals was founded by Jeffrey Bacha, Dennis M. Brown and William J. Garner on June 24, 2009 and is headquartered in Vancouver, Canada.

Contact Information

DelMar Pharmaceuticals, Inc.
999 West Broadway
Vancouver British Columbia V5Z 1K5
P:(604) 629-5989
Investor Relations:



Individual stakeholders21.43%
Mutual fund holders--
Other institutional--

Top Executives

Jeffrey A. BachaChairman, President & Chief Executive Officer
Scott PraillChief Financial Officer
Dennis M. BrownDirector & Chief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.